Get started
Work

Reproducibility of outcomes in sequential trials using CMV-targeted dendritic cell vaccination for glioblastoma.

Year: 2022
Type: conference-abstract
DOI: 10.1200/jco.2022.40.16_suppl.2005
Authors: John H. Sampson, Kristen A Batich, Duane Anthony Mitchell, James Emmett Herndon, Gloria Broadwater, Patrick Healy, Luis Sanchez-Perez, Smita Nair, Kendra Congdon, Pamela Norberg, Kent J. Weinhold, Gerald E. Archer, Elizabeth A. Reap, Weihua Xie, Roger E. McLendon, David A. Reardon, James J. Vredenburgh, Henry S. Friedman, Darell Bigner, Allan H. Friedman
Institutions: Duke Medical Center, Duke University, University of Florida, Duke Cancer Institute, Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Saint Francis Hospital & Medical Center
Language: English
Subfield: Genetics
Field: Medicine
Open Access status: closed
OpenAlex ID: W4281649965
Cites:
Cited by: 12
Related to: 10